Edition:
United States

Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

9.19USD
3:59pm EST
Change (% chg)

$-0.14 (-1.50%)
Prev Close
$9.33
Open
$9.36
Day's High
$9.40
Day's Low
$9.04
Volume
19,881
Avg. Vol
37,298
52-wk High
$15.48
52-wk Low
$7.14

CNCE.OQ

Chart for CNCE.OQ

About

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others segment. It has clinical candidates under... (more)

Overall

Beta: --
Market Cap(Mil.): $207.82
Shares Outstanding(Mil.): 22.27
Dividend: --
Yield (%): --

Financials

  CNCE.OQ Industry Sector
P/E (TTM): -- 46.85 29.68
EPS (TTM): -1.71 -- --
ROI: -31.13 -3.61 13.06
ROE: -33.77 5.27 14.19

BRIEF-Concert pharmaceuticals provides further details on CTP-656 development in U.S. and Europe

* Concert Pharmaceuticals provides further details on CTP-656 development in U.S. and Europe

Jan 17 2017

BRIEF-Concert Pharmaceuticals reports Q3 loss per share $0.51

* Concert Pharmaceuticals Inc qtrly total revenue $26,000 versus $1.7 million

Nov 08 2016

BRIEF-Concert Pharmaceuticals expands management team

* Concert Pharmaceuticals inc says appointment of two executives to support advancement of product pipeline

Sep 06 2016

More From Around the Web

Earnings vs. Estimates